D. Manor et al., IMPROVED METHOD FOR DIAGNOSIS OF POLYCYTHEMIA-VERA BASED ON FLOW CYTOMETRIC ANALYSIS OF AUTONOMOUS GROWTH OF ERYTHROID PRECURSORS IN LIQUIDCULTURE, American journal of hematology, 54(1), 1997, pp. 47-52
''Autonomous'' development of erythroid colonies in erythropoietin (EP
O)-free semi-solid culture has been used as an in vitro assay for diag
nosis of polycythemia vera (PV). These colonies, however, are small an
d poorly hemoglobinized, rendering the assay in many cases unreliable.
We report here on the use of a novel assay; it combines a modified cu
lture procedure that maximizes the growth of EPO-independent erythroid
cells, and immunofluorescence flow cytometry for their detection and
quantitation. Peripheral blood mononuclear cells are cultured for 2-5
days in the presence of a combination of growth factors. During this p
hase, early erythroid committed progenitors, burst forming units (BFUe
), proliferate and differentiate into colony forming units (CFUe)-like
progenitors. In the second phase, the latter cells, in the presence o
f stem cell factor, hemin, and iron-saturated transferrin, continue to
proliferate and mature into hemoglobin (Hb)-containing orthochromatic
normoblasts. Neither phases contained EPO. The culture produced large
, pure, and synchronized erythroid cell populations. The cells were th
en dually labeled with fluorescent probes, nuclear DNA with thiazole o
range and intracellular hemoglobin (Hb) with phycoerythrin-conjugated
monoclonal antibodies against human Hb. Cells positive for both labels
were assigned as Hb-containing nucleated precursors. The presence of
such cells in EPO-free cultures indicated ''autonomous growth.'' None
of the EPO-free cultures derived from normal donors or patients with s
econdary polycythemia contained such cells. Cultures derived from PV p
atients contained from 5 to 92% ''autonomously-grown'' cells. These cu
lture and analysis methods should minimize false negative results with
PV patients and provide objective and quantitative data. (C) 1997 Wil
ey-Liss, Inc.